Universe Pharmaceuticals, Inc. (UPC)
Universe Pharmaceuticals will go public soon, but the exact IPO date is still unknown.
Stock Price: $5.00 - $7.00
Current IPO price range
| Market Cap | 126.00M |
| Revenue (ttm) | 31.49M |
| Net Income (ttm) | 8.55M |
| Shares Out | 21.00M |
| EPS (ttm) | 0.41 |
| PE Ratio | 14.74 |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | n/a |
| Last Price | n/a |
| Previous Close | n/a |
| Change ($) | n/a |
| Change (%) | n/a |
| Day's Open | n/a |
| Day's Range | n/a |
| Day's Volume | n/a |
| 52-Week Range | n/a |
News
There are no news available yet.
About UPC
Universe Pharmaceuticals is a pharmaceutical company based in Jiangxi, China, specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (“TCMD”) products targeting the elderly with the goal of addressing their physical conditions in the aging process and to promote their general well-being. We have registered and obtained approval for 26 varieties of TCMD products from the National Medical Products Administration (the “NMPA”), and we currently produce 13 varieties of TCMD products, ... [Read more...]
| CEO Gang Lai | Employees 176 |
| Stock Exchange NASDAQ | Ticker Symbol UPC |